The arginine mimicking beta-amino acid beta(3)hPhe(3-H(2)N-CH(2)) as S1 ligand in cyclotheonamide-based beta-tryptase inhibitors

Janke D, Sommerhoff CP, Schaschke N (2011)
Bioorganic & Medicinal Chemistry 19(23): 7236-7243.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Janke, DennisUniBi; Sommerhoff, Christian P.; Schaschke, NorbertUniBi
Abstract / Bemerkung
beta-Tryptase, a mast-cell specific serine protease with trypsin-like activity, has emerged in the last years as a promising novel therapeutic target in the field of allergic inflammation. Recently, we have developed a potent and selective beta-tryptase inhibitor based on the natural product cyclotheonamide E4 by implementing a basic P3 residue that addresses the determinants of the extended substrate specificity of beta-tryptase. To further improve the affinity/selectivity profile of this lead structure, we have now investigated beta-homo-3-aminomethylphenylalanine as S1 ligand. In contrast to the corresponding beta-homo amino acids derived from lysine or arginine, we demonstrate that this particular basic beta-homo amino acid is a privileged S1 ligand for the development of beta-tryptase inhibitors. Besides affinity, selectivity and reduced basicity, these novel cyclotheonamide E4 analogs show excellent stability in human plasma and serum. (C) 2011 Elsevier Ltd. All rights reserved.
Stichworte
Solid phase peptide synthesis; relationship; Structure-activity; Serine proteases; Mast cells; Cyclic peptides
Erscheinungsjahr
2011
Zeitschriftentitel
Bioorganic & Medicinal Chemistry
Band
19
Ausgabe
23
Seite(n)
7236-7243
ISSN
0968-0896
Page URI
https://pub.uni-bielefeld.de/record/2454769

Zitieren

Janke D, Sommerhoff CP, Schaschke N. The arginine mimicking beta-amino acid beta(3)hPhe(3-H(2)N-CH(2)) as S1 ligand in cyclotheonamide-based beta-tryptase inhibitors. Bioorganic & Medicinal Chemistry. 2011;19(23):7236-7243.
Janke, D., Sommerhoff, C. P., & Schaschke, N. (2011). The arginine mimicking beta-amino acid beta(3)hPhe(3-H(2)N-CH(2)) as S1 ligand in cyclotheonamide-based beta-tryptase inhibitors. Bioorganic & Medicinal Chemistry, 19(23), 7236-7243. doi:10.1016/j.bmc.2011.09.050
Janke, D., Sommerhoff, C. P., and Schaschke, N. (2011). The arginine mimicking beta-amino acid beta(3)hPhe(3-H(2)N-CH(2)) as S1 ligand in cyclotheonamide-based beta-tryptase inhibitors. Bioorganic & Medicinal Chemistry 19, 7236-7243.
Janke, D., Sommerhoff, C.P., & Schaschke, N., 2011. The arginine mimicking beta-amino acid beta(3)hPhe(3-H(2)N-CH(2)) as S1 ligand in cyclotheonamide-based beta-tryptase inhibitors. Bioorganic & Medicinal Chemistry, 19(23), p 7236-7243.
D. Janke, C.P. Sommerhoff, and N. Schaschke, “The arginine mimicking beta-amino acid beta(3)hPhe(3-H(2)N-CH(2)) as S1 ligand in cyclotheonamide-based beta-tryptase inhibitors”, Bioorganic & Medicinal Chemistry, vol. 19, 2011, pp. 7236-7243.
Janke, D., Sommerhoff, C.P., Schaschke, N.: The arginine mimicking beta-amino acid beta(3)hPhe(3-H(2)N-CH(2)) as S1 ligand in cyclotheonamide-based beta-tryptase inhibitors. Bioorganic & Medicinal Chemistry. 19, 7236-7243 (2011).
Janke, Dennis, Sommerhoff, Christian P., and Schaschke, Norbert. “The arginine mimicking beta-amino acid beta(3)hPhe(3-H(2)N-CH(2)) as S1 ligand in cyclotheonamide-based beta-tryptase inhibitors”. Bioorganic & Medicinal Chemistry 19.23 (2011): 7236-7243.

1 Zitation in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

A new approach to inhibit human β-tryptase by protein surface binding of four-armed peptide ligands with two different sets of arms.
Jiang QQ, Bartsch L, Sicking W, Wich PR, Heider D, Hoffmann D, Schmuck C., Org Biomol Chem 11(10), 2013
PMID: 23358683

27 References

Daten bereitgestellt von Europe PubMed Central.

Mast cells.
Metcalfe DD, Baram D, Mekori YA., Physiol. Rev. 77(4), 1997
PMID: 9354811
Mast cells as "tunable" effector and immunoregulatory cells: recent advances.
Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M., Annu. Rev. Immunol. 23(), 2005
PMID: 15771585
New developments in mast cell biology.
Kalesnikoff J, Galli SJ., Nat. Immunol. 9(11), 2008
PMID: 18936782
IgE in allergy and asthma today.
Gould HJ, Sutton BJ., Nat. Rev. Immunol. 8(3), 2008
PMID: 18301424
Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells.
Schwartz LB, Irani AM, Roller K, Castells MC, Schechter NM., J. Immunol. 138(8), 1987
PMID: 3549903
[Tryptase, a marker for the activation and localization of mast cells]
Ludolph-Hauser D, Rueff F, Sommerhoff CP, Przybilla B., Hautarzt 50(8), 1999
PMID: 10460298
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.
Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T., N. Engl. J. Med. 316(26), 1987
PMID: 3295549
Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis.
Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D., J. Clin. Invest. 83(5), 1989
PMID: 2468689
Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation.
van der Linden PW, Hack CE, Poortman J, Vivie-Kipp YC, Struyvenberg A, van der Zwan JK., J. Allergy Clin. Immunol. 90(1), 1992
PMID: 1629497

Sommerhoff, Curr. Pharm. Design 13(), 2007
Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret.
Franconi GM, Graf PD, Lazarus SC, Nadel JA, Caughey GH., J. Pharmacol. Exp. Ther. 248(3), 1989
PMID: 2495355
Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide.
Walls AF, Brain SD, Desai A, Jose PJ, Hawkings E, Church MK, Williams TJ., Biochem. Pharmacol. 43(6), 1992
PMID: 1562277
Tryptase-induced airway microvascular leakage in guinea pigs: involvement of tachykinins and leukotrienes.
Greenfeder S, Sehring S, McHugh N, Corboz M, Rivelli M, Anthes JC, Billah M, Egan RW, Chapman RW., Eur. J. Pharmacol. 419(2-3), 2001
PMID: 11426850
Evaluation of the substrate specificity of human mast cell tryptase beta I and demonstration of its importance in bacterial infections of the lung.
Huang C, De Sanctis GT, O'Brien PJ, Mizgerd JP, Friend DS, Drazen JM, Brass LF, Stevens RL., J. Biol. Chem. 276(28), 2001
PMID: 11335723
Granulocyte recruitment by human mast cell tryptase.
Walls AF, He S, Teran LM, Buckley MG, Jung KS, Holgate ST, Shute JK, Cairns JA., Int. Arch. Allergy Immunol. 107(1-3), 1995
PMID: 7613178
Definition of the extended substrate specificity determinants for beta-tryptases I and II.
Harris JL, Niles A, Burdick K, Maffitt M, Backes BJ, Ellman JA, Kuntz I, Haak-Frendscho M, Craik CS., J. Biol. Chem. 276(37), 2001
PMID: 11438529
Bivalent inhibition of beta-tryptase: distance scan of neighboring subunits by dibasic inhibitors.
Schaschke N, Dominik A, Matschiner G, Sommerhoff CP., Bioorg. Med. Chem. Lett. 12(6), 2002
PMID: 11959009

Podlech, Angew. Chem., Int. Ed. Engl. 34(), 1995
Bicyclic homodetic peptide libraries: comparison of synthetic strategies for their solid-phase synthesis.
Teixido M, Altamura M, Quartara L, Giolitti A, Maggi CA, Giralt E, Albericio F., J Comb Chem 5(6), 2003
PMID: 14606803
A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis.
Sommerhoff CP, Sollner C, Mentele R, Piechottka GP, Auerswald EA, Fritz H., Biol. Chem. Hoppe-Seyler 375(10), 1994
PMID: 7888081
Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta.
Sommerhoff CP, Avrutina O, Schmoldt HU, Gabrijelcic-Geiger D, Diederichsen U, Kolmar H., J. Mol. Biol. 395(1), 2009
PMID: 19852971

de, 1963

Fields, 1992
Detection of secondary amines on solid phase.
Vojkovsky T., Pept. Res. 8(4), 1995
PMID: 8527877

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 22047802
PubMed | Europe PMC

Suchen in

Google Scholar